SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia — Stella

Recruiting

Back to SARS CoV 2 Infection trials

Trial locations(2 sites)

Ethiopia

Department of Microbiology Immunology and Parasitology, Addis Ababa

Jimma University, Jimma

Key details

Sponsor

Michael Hoelscher

Collaborators

St. Paul's Hospital Millennium Medical College, Ethiopia, Jimma University

Enrollment target

~1,000 participants

Started

November 2022

Primary completion

February 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov